Because these medications act on the digestive system, its not surprising that many of the side effects are related to digestion
(off-treatment extension of a randomized trial) Podcast: The Peter Attia Drive, AMA #64: New insights on GLP-1 agonists, including lean mass and protein
A standard B-complex dose might not be potent enough to overcome the absorption issues alcohol creates
In the LEAD-5 trial, liraglutide (1.8 mg once daily) reduced HbA1c more than insulin glargine during the treatment period (26 weeks) [31]
These percentages are notably lower than those reported for CagriSema, though cross-trial comparisons are imperfect
The Evidence | W hat GLP-1 side effects look like long term STRONG EVIDENCE Strong Evidence means a clear mechanism, multiple converging human studies, and broad agreement among researchers